Medication info

Lotemax Ophthalmic Suspension 0.5% (Loteprednol Etabonate)

Prescription medicationSuspension
Ingredient · strength
Loteprednol Etabonate›5mg / 1mL
Manufacturer / importer
Bausch Health Korea
Appearance
A white plastic bottle containing a homogeneous milky suspension when shaken.
Packaging
5mL/bottle
Approval status
Active

MFDS item code 200811863 · Approved 2008.12.24

Summary

Main use
Treatment of inflammation after ophthalmic surgery, seasonal allergic conjunctivitis, and giant papillary conjunctivitis
Who uses it
Adults
Adult dosage
○ Treatment of steroid-responsive inflammation: Instill 1-2 drops into the conjunctival sac of the affected eye 4 times daily. Take care not to discontinue treatment during the course. If symptoms and signs have not improved after 2 days, reevaluate the patient. ○ Inflammation after ophthalmic surgery: Starting 24 hours after surgery, instill 1-2 drops into the conjunctival sac of the operated eye 4 times daily, and do not administer for more than 2 weeks after surgery.

Ingredients

Importer
Bausch Health Korea

Efficacy & effects

Treatment of inflammation after ophthalmic surgery, seasonal allergic conjunctivitis, and giant papillary conjunctivitis

  • Seasonal allergic conjunctivitis
  • giant papillary conjunctivitis
  • steroid-responsive inflammation
  • post-operative inflammation.
View approved original text

This medication is used to treat steroid-responsive inflammation such as seasonal allergic conjunctivitis and giant papillary conjunctivitis. It also effectively manages inflammation that may arise after ophthalmic surgery, aiding recovery. Therefore, this drug is beneficial in improving inflammatory conditions around the eyes, reducing discomfort for the patient, and maintaining eye health.

Dosage and Administration

Adult dosage

○ Treatment of steroid-responsive inflammation: Instill 1-2 drops into the conjunctival sac of the affected eye 4 times daily. Take care not to discontinue treatment during the course. If symptoms and signs have not improved after 2 days, reevaluate the patient. ○ Inflammation after ophthalmic surgery: Starting 24 hours after surgery, instill 1-2 drops into the conjunctival sac of the operated eye 4 times daily, and do not administer for more than 2 weeks after surgery.

Precautions

This medication is a corticosteroid used in the eye, and caution is necessary as long-term use may lead to serious ocular conditions such as glaucoma or cataracts. Continued use may increase the risk of eye infections, and patients with weakened corneas or scleras may experience severe side effects such as perforation. Using this medication when acute infection symptoms are present may mask or worsen the infection; hence, consultation with a physician is essential before use. Patients with a history of viral eye infections may have an increased risk of exacerbation when using this medication, so careful use is advised. Post-cataract surgery, using this medication may delay treatment or increase side effects, warranting caution. Patients with epithelial herpetic keratitis, viral eye conditions such as herpes zoster or chickenpox, mycobacterial infections of the eye, fungal infections, or allergies to this medication or other corticosteroids should not use this drug. While using this medication, various adverse reactions such as elevated intraocular pressure, vision deterioration, eye infections, and damage to ocular tissues may occur, necessitating immediate notification to medical personnel if symptoms arise. Symptoms such as itching, congestion, foreign body sensation, and photophobia in the eye may occur, and rarely systemic symptoms like headaches, rhinitis, or pharyngitis may present. This drug is for ophthalmic use only, and if used for more than 14 days, periodic eye evaluations should be conducted to adjust treatment methods. In particular, children or patients who are unable to cooperate should have intraocular pressure monitored if used for more than 10 days. Long-term use may pose a risk of fungal infections in the cornea; hence, if corneal ulcers persist, fungal infection must be evaluated. This medication is packaged in a sterile condition, so care should be taken to prevent the dropper from contacting other objects, and if redness, itching, or inflammation worsens, a physician should be consulted immediately. Contact lens wearers should refrain from wearing lenses while using this medication. Teratogenic potential has been reported in animal studies, and there is limited experience in pregnant individuals, so use in pregnancy should be avoided or approached with caution. Lactating women should also be cautious as this medication may affect the baby through breast milk. Safety and efficacy in pediatric use have not yet been sufficiently established, thus use in children is not recommended. Although there are no long-term tests regarding carcinogenicity or genotoxicity, current test results have not indicated any genotoxicity.

Side effects

Increased intraocular pressure, decreased vision and visual field, formation of posterior capsular cataract, secondary eye infections, globe perforation, abnormal vision/blurriness, burning sensation upon instillation, conjunctival edema, discharge, dry eyes, watering, foreign body sensation, itching, redness, glare, conjunctivitis, corneal abnormalities, eyelid erythema, episcleritis, eye irritation, eye pain, eye discomfort, papillae, uveitis, headache, rhinitis, pharyngitis, corneal edema, corneal erosion, conjunctival hemorrhage, dysgeusia, lens abnormalities, abnormal eye sensations, anterior inflammation, iritis, photophobia, dyspepsia, ocular complications related to medical devices, corneal transplant rejection, eye injury, hematuria

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is important to maintain storage conditions between 15 degrees and 25 degrees Celsius at room temperature. This ensures prolonged efficacy and prevents degradation of the medication.

Appearance and packaging

Appearance

A white plastic bottle containing a homogeneous milky suspension when shaken.

Package unit

5mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.